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Abstract 
 
Objective(s) 
Tuberculosis (TB) is the leading cause of mortality among the infectious diseases, especially in developing 
countries. One of the main goals in tuberculosis research is to identify antigens which have the ability of 
inducing cellular and/or humoral immunity in order to use them in diagnostic reagents or vaccine design. . The 
aim of this study was to clone and express the TB10.4 protein in Escherichia coli expression system. 
Materials and Methods 
DNA was extracted from Mycobacterium tuberculosis H37Rv. . Gene specific primers were designed using 
Gene Runner software according to sanger sequence database. Gene tb10. .4 fragment was amplified by PCR 
method and purified tb10.4 gene was cloned into pET 102/ /D vector. . Plasmid containing pET102/D-10.4 was 
transformed into competence E. coli TOP10. A positive transformant was chosen and plasmids DNA was 
isolated and subsequently transformed into competence E. coli BL21(DE3). The bacterium was induced by 
IPTG and its lysates were loaded directly onto SDS-PAGE. Purified recombinant protein was achieved using 
metal affinity chromatography (Ni-nitrilotriacetic acid). 
Results 
TB10. .4 molecule was successfully cloned, expressed, and purified. An approximately 26.4 kDa exogenous 
protein was observed on the SDS-PAGE. The recombinant protein was confirmed by DNA sequencing of 
correct insert. 
Conclusion 
The success of expressing the TB10. .4 protein could serve as a basis for further studies on the usefulness of 
the gene and its expression product in the development of subunit vaccine and diagnostic method. 
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Introduction  
Tuberculosis (TB), caused by the intracellular 
pathogen  Mycobacterium tuberculosis, is a 
major health problem in the developing world. 
It is a disease which is re-emerging as a major 
health threat in the developed countries (1).
 It 
has been estimated that one-third of the 
world's population is currently infected. More 
than 80% of the world's population is now 
vaccinated with the available live attenuated 
bacilli Calmette Guerin (BCG) vaccine and 
even with this effort; TB remains the second 
leading cause of death worldwide among all 
infectious diseases and is responsible for 
approximately 2 million deaths annually (2). 
The high mortality induced by TB has been 
attributed to various reasons: BCG inefficacy, 
HIV co-infection and appearance of multiple 
drug-resistant strains of M. tuberculosis. 
Development of new and improved vaccines 
against TB is therefore an urgent need. . One of 
the main goals in most of the studies in 
tuberculosis field is to identify antigens which 
have the ability of inducing cellular and/or 
humoral immunity in order to use them in 
diagnostic reagents or vaccine design. 
Biochemical, immunological, and biomolecular 
characterization of M. tuberculosis has opened the 
way to discovery of many new MT antigens  such 
as ESAT-6, Ag85A, Ag85B, TB16.3, and TB9.7 
(3-5) which have been shown to be useful in the 
development of  improved diagnostic methods 
and/or vaccines (6). 
The immunogenicity of proteins that are 
actively secreted by M. tuberculosis during 
growth have been shown to generate protective 
immune responses in animal models (7-12). 
Furthermore, secreted proteins of M. tuberculosis 
induce delayed type hypersensitivity responses in 
guinea pigs and antibody production in TB 
patients (13-15). For this reason, secreted proteins 
of  M. tuberculosis have attracted significant 
attention both in vaccine research and as potential 
tools for diagnostic skin test and serological 
diagnosis of TB. 
TB10. .4 is a secreted protein and belongs to 
the ESAT-6 family which is encoded by the 
Rv0288 gene located in the esx cluster 3 and 
appears  to  be  essential  for  the  virulence  of          
M. tuberculosis (16). The data obtained from 
previous studies suggest that TB10.4 protein is 
a target for antimicrobial immune responses in 
humans (17, 18). In fact TB10.4 is strongly 
recognized by BCG-vaccinated individuals as 
well as by approximately 70% of TB patients 
and induces high levels of gamma interferon 
(INF-γ) in these individuals (17). 
Considering the above information we 
sought to find and express the TB10.4 and thus 
the aim of this study was to clone and express 
the TB10.4 immunoreactive protein in E. coli 
expression system. 
 
Materials and Methods 
Mycobacteria 
M. tuberculosis H37Rv, kindly provided by Dr  
Khajekaramaddini from Pasture Institute of 
Tehran, Iran, was cultured on 
Lowenstein-Jensen (LJ) medium at 37 ˚C. 
Extraction of genomic DNA was performed by 
Cinnagen DNA extraction kit (Tehran, Iran) as 
described by manufacture. 
 
PCR cloning 
Primers were designed, based on the DNA 
sequences from the Sanger sequence database. 
Cloning was carried out directionally. The 
primers were as follows: tb10.4-sense CAC 
CAT GTC GCA AAT CAT GTA CAA CTA 
CC; tb10.4-antisense, GCC TCC CCA TTT 
GGC GGC TT. . In this system, the primers used 
include the 4 base pair sequences (CACC) 
necessary for directional cloning on the 5′ end of 
the forward primer (underlined). PCR was 
carried  by  using  35  cycles  of  amplification          
(95 ˚C for 30 sec, 60 ˚C for 45 sec, and 72 ˚C for 
60 sec) in a Techne thermocycler by using the 
pfu DNA polymerase. The DNA purification 
column was from Fermentas. The tb10.4 
blunt-end PCR product was ligated to the 
pET102/ /D-TOPO (Invitrogen) cloning vector to 
generate the recombinant plasmid pET102/ /D-
tb10.4. The recombinant plasmid was 
transformed into One Shot® TOP10 chemically 
competent E. coli (Invitrogen) by a heat shock 
method as described by manufacturer. The 
clones were selected on LB (Luria-Bertani, 
MERCK, Germany) agarose plates 
supplemented with ampicillin (100 µg/ml). 
TOP10 E. coli cells were used for cloning and  
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maintenance of plasmid DNA, whereas BL21 E. 
 coli cells (Invitrogen) were used for expression 
studies. Plasmid DNA extraction was performed 
using the QIAprep® Miniprep DNA purification 
system (Qiagen). Nucleotide sequencing was 
carried out by Seq lab (Germany). 
 
Expression and purification studies 
The purified plasmids were further introduced 
into E. coli BL21. The transformed E. coli cells 
were grown on LB solid medium containing 
ampicillin (100 µg/ml). An overnight culture 
was used to inoculate 200 ml LB broth medium 
supplemented with ampicillin. When the OD 600 
had reached 0.5 expression was induced by the 
addition of isopropyl-1-thio-β-D-galactoside 
(IPTG) to  a  final  concentration  of  2  µl/ml  for         
24 hr at 37 ˚C. The induced cells were then 
harvested by centrifugation at 4000 g for 15 min 
at 4 ˚C. Pellets were suspended in lysis buffer            
(300 mM NaCl, 50 mM Tris-HCl, pH 7.6, 100 
mM KCl, 10  % glycerol, 0.5  %Triton X) and 
frozen in liquid nitrogen and thawed in 37 ºC for 
3 times and  then centrifuged at 4000 g for 10 
min. . Both the supernatant and the pellet were 
analyzed by SDS–PAGE using a 12. .5% % 
polyacrylamide gel. The gel was stained for      4 
hr by standard coomassie brilliant blue G-250 
and destained with 45   % methanol/10% acetic 
acid solution.   The supernatant of the cell lysate 
was passed through the nickel–NTA column 
(Qiagen). . The column was washed with 15 ml 
lysis buffer containing 10 mM imidazol. . Then 
the protein passed through the column. . Next the 
column was eluted with increasing imidazole 
concentration (10, 20 and 200 mM). 
Purity of the recombinant protein was assessed 
by SDS–PAGE using a 12     % % polyacrylamide gel, 
and then dialyzed overnight against PBS at 4 °C. 
Quantitation of recombinant proteins was carried 
out using Bradford protein assay. 
 
Results  
Cloning was based on the polymerase chain 
reaction ( (PCR). . We amplified tb10. .4 from 
H37Rv genomic DNA.   To  reduce  the 
possibility of errors caused by amplification, 
we used pfu, a high-fidelity DNA polymerase 
with proofreading activity. . The PCR product 
was confirmed 291 bp DNA segment by using 
agarose gel electrophoresis, as expected 
(Figure1). 
The PCR-amplified coding region of the 
tb10. .4 gene was gel purified and inserted into 
the pET102/ /D-TOPO vector. . Recombinant 
colonies were selected on LB agar plate which 
was supplemented with ampicillin. . Only one 
white colony was picked and the tb10. .4 
recombinant plasmids were extracted from this 
clone. . Plasmid sequencing was performed in 
order to confirm the identity of cloned gene 
and to verify that the DNA encoding tb10. .4 is 
inserted in correct frame. . Alignment of 
sequence revealed that recombinant DNA was 
99% % homologous with different strains of              
M. tuberculosis.   The  recombinant  plasmids 
were then transformed into expression host             
E     . coli  BL21 (DE3). Expression of the 
recombinant protein was assessed in the 
presence of inducer IPTG. . The recombinant 
TB10. .4 was abundant in the total lysate. . As 
expected, TB10. .4 was expressed with an 
apparent molecular mass of 26. .4 kDa on SDS–
PAGE and was completely found in the 
soluble phase (Fiure 2). . 
The recombinant protein was purified by 
Ni-affinity chromatography from lysates of        
E. . coli BL21. . The flow through and wash 
fractions were collected before the gradient 
former was switched on and fraction was 
collected after increasing imidazole 
concentration (10, 20 and 200 mM). The aliquot 
from the fraction was run on SDS-PAGE. . Pure 
protein containing fraction was dialysed to get 
rid of imidazole. . The collected fractions were 
then run on SDS-PAGE (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure   1. Agarose gel electrophoresis of PCR product 
showing the amplification of gene of interest (tb10. .4). 
Lane tb10. .4:    band of 291 bp; Lane M: :100 bp DNA 
marker (Fermentas).  
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Figure  2. SDS-PAGE showing induction of the 
expressed TB10.4 protein in liquid phase before 
purification. Lane M, molecular weight markers (kDa); 
lane L, soluble protein fraction obtained from the 
Escherichia coli transformant pellet; lane S, insoluble 
protein fraction  
 
 
 
Figure  3. Coomasie blue staining of purified TB10.4 
recombinant protein. Lane M, molecular weight markers 
(kDa); lane P, purified and dialysed TB10. .4 protein 
(26. .4 KDa) 
 
Discussion 
For many years, great efforts have been made 
to develop a new vaccine against tuberculosis 
and designing better methods for the diagnosis 
of the disease. . 
Considering these facts, the TB10. .4 protein 
from the highly active low-mass fraction of 
culture filtrate has been formerly shown to 
induce strong Th1 responses following TB 
infection both in humans and animal models 
(17-20).TB10. .4 was strongly recognized by 
around 70% of the TB patients as well as by 
BCG-vaccinated individuals (17, 18). 
For the first time in 2000, TB10. .4                 
was identified in culture filtrate from                   
M. tuberculosis by Skjot et al. . The gene was 
cloned in pMST24 vector but the recombinant 
protein was expressed in inclusion body (18). .
 
In a previous study, cloning of tb10. .4 was 
achieved in pET28b vector. . The recombinant 
protein was produced as an insoluble one with 
no protein detectable in soluble fraction (21). 
In mentioned studies, the plasmid and the 
inserted gene were cut by restriction enzymes. 
In the present study, pET TOPO directional 
technology was used for cloning of TB10. .4 
from H37Rv. . Accordingly, the blunt end PCR 
product was directly inserted to the expression 
vector. . There was no need to digest the 
inserted gene or plasmid with the restriction 
enzymes. . Protein TB10. .4  was  expressed             
in  E.  . coli  expression  system  having  a           
poly  histidine  purification  tag  and  purified                  
to near-homogeneity by nickel-affinity 
chromatography. . We applied a simple method 
of releasing cytoplasmic proteins by repeated 
cycles of freezing and thawing which was 
proved to be efficient for a number of 
recombinant proteins (22).
   Another interesting 
point of our work in comparison with the 
others was that the entire TB10. .4 protein was 
expressed in liquid phase ( (Figure   2) ). 
 
Conclusion 
The success of expressing the TB10. .4 protein 
could serve as a basis for further studies on the 
usefulness of this gene and its expression 
product in the development of subunit vaccine 
and diagnostic methods. As a matter of fact, it 
is important to determine whether TB10. .4 
evokes immune responses in TB patients and 
BCG vaccinated healthy subjects in an 
endemic region. We are currently working on 
the process of optimizing enzyme-linked 
immunosorbent assay (ELISA) with TB10.4 
recombinant protein for serological diagnosis 
of tuberculosis.  
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